Last reviewed · How we verify

NCT03920514

Timing and Intrauterine Insemination in Unexplained Infertility

Status unknown Phase 4 Last updated 19 April 2019
What this trial tests

Phase 4 trial testing hCG in Intrauterine Insemination in 80 participants. Status unknown.

Timeline
30 April 2019
Primary endpoint
30 September 2019
31 December 2019

Quick facts

Lead sponsorSohag University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment80
Start date30 April 2019
Primary completion30 September 2019
Estimated completion31 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 18 to 40, female only, with Intrauterine Insemination. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

to determine the most suitable time for administration of (human chorionic gonadotropin )hCG prior to intrauterine insemination (IUI) to optimize pregnancy outcome and to have the best success rates so the cases divided in to four groups according to the time of hCG administration .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of hCG

Trials testing the same drug.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03920514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing